Journal Mobile Options
Table of Contents
Vol. 118, No. 2-4, 1999
Issue release date: February–April 1999

Implications of the Grass Group I Allergens on the Sensitization and Provocation Process

Petersen A. · Grobe K. · Schramm G. · Vieths S. · Altmann F. · Schlaak M. · Becker W.-M.
Int Arch Allergy Immunol 1999;118:411–413 (DOI:10.1159/000024150)
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Grass pollen allergens of group I are particularly important because of their high IgE prevalence and occurrence in all grass species. Four independent IgE–binding regions and one continous epitope were identified. The posttranslational modifications on the molecule increased allergenicity. Phl p 1 is a cysteine protease, as determined by specific substrates, inhibitors and consensus sequence motifs. In analogy to other allergens and/or proteases, we deduce that Phl p 1 might enhance the permeability of the epithelium, influence T helper cells to bias Th2, and increase the IgE production of plasma cells. Thus, the group I allergens seem to be the crucial components in a pollen extract which can mediate sensitization and enhance the triggering of symptoms leading to the persistence of a grass pollen allergy.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Petersen A, Schramm G, Bufe A, Schlaak M, Becker WM: Structural investigations of the major allergen Phl p I on the cDNA and protein level. J Allergy Clin Immunol 1995;95:987– 994.

    External Resources

  2. Schramm G, Bufe A, Petersen A, Haas H, Schlaak M, Becker WM: Mapping of IgE binding epitopes on the recombinant major group I allergen of velvet grass pollen, rHol l 1. J Allergy Clin Immunol 1997;99:781–787.
  3. Petersen A, Schlaak M, Becker WM: Post–translational modifications of allergens and their influence on IgE reactivity; in Oehling AK, Huerta Lopez JG (eds): Progress in Allergy and Clinical Immunology. Seattle, Hogrefe & Huber, 1997, vol 4, pp 139–143.
  4. Petersen A, Becker WM, Moll H, Blümke M, Schlaak M: Determination of the carbohydrate structure of the timothy grass pollen allergen Phl p I. Electrophoresis 1995;16:869–875.
  5. Petersen A, Schramm G, Schlaak M, Becker WM: Posttranslational modifications influence IgE reactivity to the major allergen Phl p 1 of timothy grass pollen. Clin Exp Allergy 1998;28:315–321.

    External Resources

  6. Grobe K, Becker WM, Schlaak M, Petersen A: Grass group I allergens (β–expansins) are members of the C1 family of cysteine pro– teases. Eur J Biochem, in press.
  7. Rawlings ND, Barrett AJ: Families of cysteine peptidases. Method Enzymol 1994;244:461– 711.
  8. Stewart GA, Thompson PJ, McWilliam AS: Biochemical properties of aeroallergens: Contributory factors in allergic sensitization? Pediatr Allergy Immunol 1993;4:163–172.
  9. Schulz O, Sewell HF, Shakib F: Proteolytic cleavage of CD25, the alpha subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity. J Exp Med 1998;187:271–275.
  10. Hewitt CRA, Brown AP, Hart BJ, Pritchard DI: A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23. J Exp Med 1995;182:1537– 1544.
  11. Schulz O, Sutton BJ, Beavil RL, Shi J, Sewell HF, Gould HJ, Laing P, Shakib F: Cleavage of the low affinity receptor for human IgE (CD23) by a mite cysteine proteinase: Nature of the cleaved fragment in relation to the structure and function of CD23. Eur J Immunol 1997;27:584–588.

    External Resources

  12. Sherr E, Macy E, Kimata H, Gilly M, Saxon A: Binding the low affinity FcεR on B cells suppresses ongoing human IgE synthesis. J Immunol 1989;142:481–489.
  13. Aubry JP, Pochon S, Graber P, Jansen KU, Bonnefoy JY: CD21 is a ligand for CD23 and regulates IgE production. Nature 1992;358: 505–507.
  14. Isemura S, Saitoh E, Isemura M, Sanada K: Cystatin S: A cysteine proteinase inhibitor of human saliva. J Biochem 1984;96:1311–1314.

    External Resources



Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00